These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28566582)

  • 1. [Evaluation of the Effects of Pharmacist Intervention for Adverse Drug Reaction Detection and Exacerbation Avoidance].
    Imaura M; Yamaya T; Uehara N; Mano N; Nagase S; Kimura K; Kanno H; Yamada Y
    Yakugaku Zasshi; 2017; 137(6):767-774. PubMed ID: 28566582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of the Clinical Pharmacist in a Preventive Cardiology Practice.
    Warden BA; Shapiro MD; Fazio S
    Ann Pharmacother; 2019 Dec; 53(12):1214-1219. PubMed ID: 31342786
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacists' role in detection and evaluation of adverse drug reactions: Developing proactive systems for pharmacosurveillance.
    Salazar A; Amato MG; Shah SN; Khazen M; Aminmozaffari S; Klinger EV; Volk LA; Mirica M; Schiff GD
    Am J Health Syst Pharm; 2023 Feb; 80(4):207-214. PubMed ID: 36331446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Avoidance of Adverse Drug Reactions by Pharmacists (Through the PreAVOID Report)].
    Tanigawa K
    Rinsho Byori; 2016 Sep; 64(9):1082-1084. PubMed ID: 30609463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Drug Therapy-Related Issues in an Outpatient Heart Failure Population and the Potential Impact of Pharmacist-Driven Intervention.
    Dempsey JT; Matta LS; Carter DM; Stevens CA; Stevenson LW; Desai AS; Cheng JW
    J Pharm Pract; 2017 Jun; 30(3):318-323. PubMed ID: 27080398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving medication safety and diabetes management in Hong Kong: a multidisciplinary approach.
    Chung AY; Anand S; Wong IC; Tan KC; Wong CF; Chui WC; Chan EW
    Hong Kong Med J; 2017 Apr; 23(2):158-67. PubMed ID: 28302923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-related problems identification in general internal medicine: The impact and role of the clinical pharmacist and pharmacologist.
    Guignard B; Bonnabry P; Perrier A; Dayer P; Desmeules J; Samer CF
    Eur J Intern Med; 2015 Jul; 26(6):399-406. PubMed ID: 26066400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the suspicious renal pharmacist in identifying unusual adverse drug reactions-why this is not a small problem.
    Coulter CV
    Int J Clin Pharm; 2018 Aug; 40(4):775-777. PubMed ID: 29855988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-outcome description of clinical pharmacist interventions in a university teaching hospital.
    Gallagher J; Byrne S; Woods N; Lynch D; McCarthy S
    BMC Health Serv Res; 2014 Apr; 14():177. PubMed ID: 24742158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the clinical pharmacist in reducing mortality in hospitalized cardiac patients: A prospective, nonrandomized controlled trial using propensity score methods.
    Zhai XB; Tian DD; Liu XY
    Int J Clin Pharmacol Ther; 2015 Mar; 53(3):220-9. PubMed ID: 25546163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geriatric Polypharmacy: Pharmacist as Key Facilitator in Assessing for Falls Risk: 2019 Update.
    Fritsch MA; Shelton PS
    Clin Geriatr Med; 2019 May; 35(2):185-204. PubMed ID: 30929882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacists contribute to the safety of medicines].
    Nishihara S
    Yakugaku Zasshi; 2011; 131(6):865-9. PubMed ID: 21628969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guiding pharmacist clinical interviews: a safety tool to support the education of patients treated with oral antineoplastic agents.
    Ribed A; Escudero-Vilaplana V; Romero-Jimenez RM; Iglesias-Peinado I; Herranz-Alonso A; Sanjurjo-Saez M
    Expert Opin Drug Saf; 2016; 15(4):427-35. PubMed ID: 26854363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADVERSE DRUG REACTIONS: FACTORS AND ROLE OF PHARMACIST IN THEIR PREVENTION.
    Bushra R; Baloch SA; Jabeen A; Bano N; Aslam N
    J Ayub Med Coll Abbottabad; 2015; 27(3):702-6. PubMed ID: 26721044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for Adverse Drug Events: a Randomized Trial of Automated Calls Coupled with Phone-Based Pharmacist Counseling.
    Schiff GD; Klinger E; Salazar A; Medoff J; Amato MG; John Orav E; Shaykevich S; Seoane EV; Walsh L; Fuller TE; Dykes PC; Bates DW; Haas JS
    J Gen Intern Med; 2019 Feb; 34(2):285-292. PubMed ID: 30291602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist Interventions for Adverse Drug Reactions in Palliative Care: A Multicentre Pilot Study.
    Kose E; Nakagawa S; Niki K; Hashizume J; Kawazoe T; Suzuki N; Uchida M; Takase H
    Pharmazie; 2023 Aug; 78(8):141-149. PubMed ID: 37592417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of sotalol prescribing in a community hospital: opportunities for clinical pharmacist involvement.
    Finks SW; Rogers KC; Manguso AH
    Int J Pharm Pract; 2011 Aug; 19(4):281-6. PubMed ID: 21733016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of an active pharmacovigilance system carried out by a pharmacist].
    Sánchez I; Amador C; Plaza JC; Correa G; Amador R
    Rev Med Chil; 2014 Aug; 142(8):998-1005. PubMed ID: 25424672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differences in the assessments of side effects at an oncology outpatient clinic.
    Bayraktar-Ekincioglu A; Kucuk E
    Int J Clin Pharm; 2018 Apr; 40(2):386-393. PubMed ID: 29353396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a transition-of-care pharmacist during hospital discharge.
    Balling L; Erstad BL; Weibel K
    J Am Pharm Assoc (2003); 2015; 55(4):443-8. PubMed ID: 26161488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.